BACKGROUND: The Barcelona Clinic Liver Cancer(BCLC)staging system for hepatocellular carcinoma(HCC) recommends transarterial chemoembolization(TACE) as the first line therapy for stage B patients and sorafenib ...BACKGROUND: The Barcelona Clinic Liver Cancer(BCLC)staging system for hepatocellular carcinoma(HCC) recommends transarterial chemoembolization(TACE) as the first line therapy for stage B patients and sorafenib treatment for stage C patients.However, stage C patients exhibit variations in terms of tumor burden, liver function, and extrahepatic metastasis, which could potentially affect disease outcome. Here, we assessed whether the Cancer of the Liver Italian Program(CLIP) scores can help identify stage C patients likely to benefit from TACE.METHODS: Out of 295 BCLC stage C HCC patients enrolled between January 2009 and December 2011, those with platelet counts 〉30×10~9 cells/L, total bilirubin 〈51 μmo L/L, and an unobstructed main portal vein were scheduled for TACE(n=195). The remaining patients received best supportive care(BSC, n=100).All the patients were followed up for symptoms, performance status, and Child-Pugh classification scores every 4 weeks until death or December 2013. The prognosis of each group was evaluated by using the log-rank test and Cox-Mantel test.RESULTS: The median overall survival(OS) was 6 months [95% confidence interval(CI): 4.64-7.36]. The OS was 9 months for the TACE group and 4 months for the BSC group. The TACE group had a longer OS than the BSC subgroup for CLIP scores 0-2 [13 months(95% CI: 8.55-17.45) vs 4 months(95% CI:0.00-10.96), P=0.001]. No significant differences were found between the TACE and BSC groups for CLIP scores 3-5. The CLIP score and treatment methods were found to be independent prognostic factors.CONCLUSIONS: BCLC stage C HCC patients exhibit definite disease heterogeneity and can be reclassified by using the CLIP scoring system. Moreover, patients with CLIP scores 0-2 are likely to benefit from TACE. However, additional studies with long-term follow-up will be required to validate these findings.展开更多
Graphene oxide(GO)wrapped Fe_(3)O_(4) nanoparticles(NPs)were prepared by coating the Fe_(3)O_(4) NPs with a SiO_(2) layer,and then modifying by amino groups,which interact with the GO nanosheets to form covalent bondi...Graphene oxide(GO)wrapped Fe_(3)O_(4) nanoparticles(NPs)were prepared by coating the Fe_(3)O_(4) NPs with a SiO_(2) layer,and then modifying by amino groups,which interact with the GO nanosheets to form covalent bonding.The SiO_(2) coating layer plays a key role in integrating the magnetic nanoparticles with the GO nanosheets.The effect of the amount of SiO_(2) on the morphology,structure,adsorption,and regenerability of the composites was studied in detail.An appropriate SiO_(2) layer can effectively induce the GO nanosheets to completely wrap the Fe_(3)O_(4) NPs,forming a core-shell Fe_(3)O_(4)@SiO_(2)@GO composite where Fe_(3)O_(4)@SiO_(2) NPs are firmly encapsulated by GO nanosheets.The optimized Fe_(3)O_(4)@SiO_(2)@GO sample exhibits a high saturated adsorption capacity of 253 mg·g^(-1) Pb(Ⅱ)cations from wastewater,and the adsorption process is well fitted by Langmuir adsorption model.Notably,the composite displays excellent regeneration,maintaining a~90%adsorption capacity for five cycles,while other samples decrease their adsorption capacity rapidly.This work provides a theoretical guidance to improve the regeneration of the GO-based adsorbents.展开更多
Aim: This study explored the correlation between the expression of excision repair cross-complementation group 1 (ERCC1) and the prognosis of gastric cancer patients. Methods: From January 2005 to December 2008, 6...Aim: This study explored the correlation between the expression of excision repair cross-complementation group 1 (ERCC1) and the prognosis of gastric cancer patients. Methods: From January 2005 to December 2008, 605 patients who underwent radical surgery in The First Affiliated Hospital of Nanjing Medical University were enrolled. We conducted the follow-up every 6 months and its contents included a comprehensive medical history, tumor markers and abdominal ultrasound or CT and other imaging findings. Deadline was April 30, 2013 and follow-up time between 51 to 91 months. Survival time is calculated from the date of diagnosis to death or last follow-up date. Immunohistochemistry (IHC) was used to assess the expression of ERCCI in resected samples. The relationship between ERCCI expression and survival of patients was investigated. The comparison of count data were analyzed by Chi-square test. Median survival time (MST) and the 5-year survival rate were calculated by life table analysis. The Kaplan-Meier curves were used for survival analysis. Results: ERCC1 expression was positive in 412 patients (68.1%). There is no significant difference between ERCCl-positive group and ERCCl-negative group in terms of the MST and 5-year survival rate (P=0.455). The MST and 5-year survival rate have no significant difference (P=0.162) between group with chemotherapy and group with no chemotherapy in patients with ERCCl-positive expression. However, the MST and 5-year survival rate in patients with ERCCl-negative expression benefited more from with chemotherapy (P=0.019). The ERCCl-positive patients survived longer than those ERCCl-negative patients (P=0.183) in subgroup with no adjuvant chemotherapy. In the subgroup analysis, ERCC 1 expression had no significant relationship with overall survival in patients with stage II or llI gastric cancer (P〉0.05). Conclusions: ERCC1 might be a good prognostic factor for the patients of gastric cancer after radical resection. Patients with ERCCl-negative expression could benefit more from adjuvant chemotherapy.展开更多
As prospective energy storage devices,zinc-ion hybrid capacitors(ZHCs)still suffer from unsatisfactory cathode materials.Herein,the three dimensional(3D)N,B dual-doped carbon quantum dots/reduced graphene oxide(N,B-CQ...As prospective energy storage devices,zinc-ion hybrid capacitors(ZHCs)still suffer from unsatisfactory cathode materials.Herein,the three dimensional(3D)N,B dual-doped carbon quantum dots/reduced graphene oxide(N,B-CQDs/rGO)composite aerogel is prepared via a onepot hydrothermal method.Thanks to the synergism of CQDs modification and N,B dual-doping,the resultant N,B-CQDs/rGO composite aerogel delivers superior electrochemical properties.Furthermore,the as-obtained N,B-CQDs/rGO composite aerogel is served as a cathode for aqueous and flexible quasi-solid-state ZHCs for the first time.Impressively,the aqueous N,B-CQDs/rGO//Zn ZHC manifests a large energy density of 96.2 Wh·kg^(-1)at80 W·kg^(-1)and still remains a high energy density of 54.7Wh·kg^(-1)at a superb power density of 80 kW·kg^(-1).Meanwhile,kinetic analyses are employed to elucidate the prominent power performance,and various ex situ tests are undertaken to explore the energy storage mechanism of aqueous ZHC.More notably,the flexible quasi-solid-state N,B-CQDs/rGO//Zn ZHC displays a desirable energy density(89.1μWh·cm^(-2)),a superior power density(96,000μW·cm^(-2))and exceptional flexible performance.The present study offers a valuable reference for designing and developing advanced cathode materials for aqueous and flexible quasi-solid-state ZHCs.展开更多
基金supported by grants from You’an Liver disease/AIDS funding(2011)the National Science&Technology Pillar Program during the 12th Five-year Plan Period(2013BAI13B04)
文摘BACKGROUND: The Barcelona Clinic Liver Cancer(BCLC)staging system for hepatocellular carcinoma(HCC) recommends transarterial chemoembolization(TACE) as the first line therapy for stage B patients and sorafenib treatment for stage C patients.However, stage C patients exhibit variations in terms of tumor burden, liver function, and extrahepatic metastasis, which could potentially affect disease outcome. Here, we assessed whether the Cancer of the Liver Italian Program(CLIP) scores can help identify stage C patients likely to benefit from TACE.METHODS: Out of 295 BCLC stage C HCC patients enrolled between January 2009 and December 2011, those with platelet counts 〉30×10~9 cells/L, total bilirubin 〈51 μmo L/L, and an unobstructed main portal vein were scheduled for TACE(n=195). The remaining patients received best supportive care(BSC, n=100).All the patients were followed up for symptoms, performance status, and Child-Pugh classification scores every 4 weeks until death or December 2013. The prognosis of each group was evaluated by using the log-rank test and Cox-Mantel test.RESULTS: The median overall survival(OS) was 6 months [95% confidence interval(CI): 4.64-7.36]. The OS was 9 months for the TACE group and 4 months for the BSC group. The TACE group had a longer OS than the BSC subgroup for CLIP scores 0-2 [13 months(95% CI: 8.55-17.45) vs 4 months(95% CI:0.00-10.96), P=0.001]. No significant differences were found between the TACE and BSC groups for CLIP scores 3-5. The CLIP score and treatment methods were found to be independent prognostic factors.CONCLUSIONS: BCLC stage C HCC patients exhibit definite disease heterogeneity and can be reclassified by using the CLIP scoring system. Moreover, patients with CLIP scores 0-2 are likely to benefit from TACE. However, additional studies with long-term follow-up will be required to validate these findings.
基金financially supported by the Natural Science Foundation of Hunan Province,China(No.2020JJ4269)the Natural Science Foundation of China(No.21576075)。
文摘Graphene oxide(GO)wrapped Fe_(3)O_(4) nanoparticles(NPs)were prepared by coating the Fe_(3)O_(4) NPs with a SiO_(2) layer,and then modifying by amino groups,which interact with the GO nanosheets to form covalent bonding.The SiO_(2) coating layer plays a key role in integrating the magnetic nanoparticles with the GO nanosheets.The effect of the amount of SiO_(2) on the morphology,structure,adsorption,and regenerability of the composites was studied in detail.An appropriate SiO_(2) layer can effectively induce the GO nanosheets to completely wrap the Fe_(3)O_(4) NPs,forming a core-shell Fe_(3)O_(4)@SiO_(2)@GO composite where Fe_(3)O_(4)@SiO_(2) NPs are firmly encapsulated by GO nanosheets.The optimized Fe_(3)O_(4)@SiO_(2)@GO sample exhibits a high saturated adsorption capacity of 253 mg·g^(-1) Pb(Ⅱ)cations from wastewater,and the adsorption process is well fitted by Langmuir adsorption model.Notably,the composite displays excellent regeneration,maintaining a~90%adsorption capacity for five cycles,while other samples decrease their adsorption capacity rapidly.This work provides a theoretical guidance to improve the regeneration of the GO-based adsorbents.
基金support by the National Natural Science Foundation of China (Grant number: 81171908, 81100274 and 81201705)Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
文摘Aim: This study explored the correlation between the expression of excision repair cross-complementation group 1 (ERCC1) and the prognosis of gastric cancer patients. Methods: From January 2005 to December 2008, 605 patients who underwent radical surgery in The First Affiliated Hospital of Nanjing Medical University were enrolled. We conducted the follow-up every 6 months and its contents included a comprehensive medical history, tumor markers and abdominal ultrasound or CT and other imaging findings. Deadline was April 30, 2013 and follow-up time between 51 to 91 months. Survival time is calculated from the date of diagnosis to death or last follow-up date. Immunohistochemistry (IHC) was used to assess the expression of ERCCI in resected samples. The relationship between ERCCI expression and survival of patients was investigated. The comparison of count data were analyzed by Chi-square test. Median survival time (MST) and the 5-year survival rate were calculated by life table analysis. The Kaplan-Meier curves were used for survival analysis. Results: ERCC1 expression was positive in 412 patients (68.1%). There is no significant difference between ERCCl-positive group and ERCCl-negative group in terms of the MST and 5-year survival rate (P=0.455). The MST and 5-year survival rate have no significant difference (P=0.162) between group with chemotherapy and group with no chemotherapy in patients with ERCCl-positive expression. However, the MST and 5-year survival rate in patients with ERCCl-negative expression benefited more from with chemotherapy (P=0.019). The ERCCl-positive patients survived longer than those ERCCl-negative patients (P=0.183) in subgroup with no adjuvant chemotherapy. In the subgroup analysis, ERCC 1 expression had no significant relationship with overall survival in patients with stage II or llI gastric cancer (P〉0.05). Conclusions: ERCC1 might be a good prognostic factor for the patients of gastric cancer after radical resection. Patients with ERCCl-negative expression could benefit more from adjuvant chemotherapy.
基金financially supported by the Distinguished Young Scientists of Hunan Province(No.2022JJ10024)the National Natural Science Foundation of China(No.21601057)+1 种基金the Natural Science Foundation of Hunan Province(No.2021JJ30216)Key Projects of Hunan Provincial Education Department(No.22A0412)。
文摘As prospective energy storage devices,zinc-ion hybrid capacitors(ZHCs)still suffer from unsatisfactory cathode materials.Herein,the three dimensional(3D)N,B dual-doped carbon quantum dots/reduced graphene oxide(N,B-CQDs/rGO)composite aerogel is prepared via a onepot hydrothermal method.Thanks to the synergism of CQDs modification and N,B dual-doping,the resultant N,B-CQDs/rGO composite aerogel delivers superior electrochemical properties.Furthermore,the as-obtained N,B-CQDs/rGO composite aerogel is served as a cathode for aqueous and flexible quasi-solid-state ZHCs for the first time.Impressively,the aqueous N,B-CQDs/rGO//Zn ZHC manifests a large energy density of 96.2 Wh·kg^(-1)at80 W·kg^(-1)and still remains a high energy density of 54.7Wh·kg^(-1)at a superb power density of 80 kW·kg^(-1).Meanwhile,kinetic analyses are employed to elucidate the prominent power performance,and various ex situ tests are undertaken to explore the energy storage mechanism of aqueous ZHC.More notably,the flexible quasi-solid-state N,B-CQDs/rGO//Zn ZHC displays a desirable energy density(89.1μWh·cm^(-2)),a superior power density(96,000μW·cm^(-2))and exceptional flexible performance.The present study offers a valuable reference for designing and developing advanced cathode materials for aqueous and flexible quasi-solid-state ZHCs.